✓ Evidence-based health information Editorial Policy  |  Medical Review Board
Emergency Care

Overdose Emergency: Recognizing Signs and Using Narcan

Written by Dr. Thomas Reed, MD, PhD, MD, PhD
Published
Updated
9 min read
Share: Facebook Tweet
Medically Reviewed This article has been reviewed for accuracy by the HealthTopics Medical Team. Our editorial process ensures content meets rigorous accuracy standards.
Overdose Emergency: Recognizing Signs and Using Narcan
Overdose Emergency: Recognizing Signs and Using Narcan – HealthTopics.com

Overdose Emergency: What Most People Get Wrong About Recognition and Narcan

Marcus is 34, works in construction, and thought he knew the signs of an overdose—someone passed out, maybe not breathing. When his brother took what he thought was a Percocet at a family dinner but was actually counterfeit fentanyl mixed with xylazine, Marcus didn’t recognize the emergency unfolding. His brother’s eyes were pinpoint, yes, but he was still conscious, still responding to questions, just… slower. Drowsy. Marcus waited twenty minutes before calling 911. By then, his brother had stopped responding entirely. Here’s what most people don’t realize: overdose isn’t a binary switch between “fine” and “unconscious.” It’s a spectrum with a critical window where intervention saves lives.

The medical truth about overdose emergencies contradicts what television has taught us. Most overdose deaths don’t happen at the moment someone loses consciousness—they happen in the period afterward when respiratory depression deepens, when the brain’s control centers shut down oxygen delivery to vital organs. And here’s the part that changes everything: Narcan (naloxone) works best when administered during that intermediate phase, not after someone has been unresponsive for hours. Understanding the actual timeline and recognizing the subtle warning signs in that window is what separates a dramatic save from a tragedy.

Key Facts About Overdose Emergency

  • According to the CDC, synthetic opioids were involved in over 70% of all opioid overdose deaths in 2021, with fentanyl being the primary culprit—and today’s street fentanyl is often mixed with xylazine or benzodiazepines, complicating recognition and treatment response
  • The Journal of the American Medical Association (JAMA) reported that naloxone administration within the first 2-3 minutes of respiratory depression dramatically improves survival outcomes, yet the average time from symptom onset to Narcan administration remains 11-15 minutes in community settings
  • Approximately 100 people die daily from drug overdoses in the United States, with opioids involved in roughly 68% of these deaths, yet naloxone kits reach fewer than 10% of people at high risk
  • Narcan effectiveness depends on the type of opioid involved—standard naloxone reverses heroin or prescription oxycodone in 3-5 minutes, but fentanyl-xylazine combinations may require multiple doses or even IV naloxone in emergency settings
  • Non-opioid sedatives and stimulants (cocaine, methamphetamine) commonly combined with opioids in overdose situations do not respond to naloxone, requiring EMS intervention for complete reversal and monitoring

Understanding What Happens During an Overdose Emergency

Think of your brain’s respiratory center as a dimmer switch rather than an on-off button. When opioids bind to receptors in the brainstem, they gradually turn down that switch. At first, breathing just becomes shallow and slower—you might not notice it. The body is still getting enough oxygen. But as more opioid molecules bind, the switch dims further until the brain essentially stops sending the signal to breathe at all. Carbon dioxide accumulates in the blood, the pH drops, and cells throughout the body begin suffocating from the inside out.

What makes this mechanism particularly dangerous with modern street drugs is that fentanyl—which is 50 to 100 times more potent than morphine—can complete this dimming process in minutes. Someone might feel warm, drowsy, maybe euphoric initially, and then within 5-10 minutes they’re in severe respiratory depression without ever remembering the transition. The other part most people don’t understand: the body doesn’t just stop breathing and die instantly. There’s often a 30-60 minute window where the person is profoundly unresponsive but their heart is still beating and their brain hasn’t suffered permanent damage yet. That’s the window when Narcan works.

Causes and Risk Factors for Overdose Emergency

The obvious risk factors—using opioids, mixing substances, using alone—matter enormously. But here’s what gets overlooked: tolerance loss is a genuinely dangerous factor that separates occasional users from people who think they can use safely. Someone who hasn’t used opioids in three weeks loses 50% of their tolerance. Someone who stops for three months loses 80%. That person relapses and uses the same dose they used to handle, and suddenly their body doesn’t have the protective adaptation it once did. The overdose is almost inevitable.

Other critical risk factors include previous overdose (which predicts future overdose), concurrent benzodiazepine use (which potentiates respiratory depression), alcohol consumption, and using with unfamiliar sources of drugs. The less commonly discussed factor: environmental stress and untreated mental health conditions. Research shows that people actively in crisis—dealing with unaddressed depression, untreated PTSD, or acute trauma—have overdose rates 3-4 times higher than their peers, even when controlling for substance access. This isn’t just about the drug itself; it’s about why someone reaches for it in a desperate moment.

Xylazine, increasingly mixed into heroin and fentanyl supplies, creates a unique risk profile. It causes respiratory depression that doesn’t fully respond to naloxone, meaning someone can receive Narcan, briefly wake up, and then re-sedate as the xylazine remains active. Polysubstance use—whether intentional mixing or unknowing consumption of contaminated drugs—dramatically raises overdose mortality because no single antidote addresses all the drugs involved.

Signs and Symptoms in Overdose Emergency

The early warning signs appear before someone loses consciousness, and catching them means you have time to act. Look for pinpoint pupils—this is nearly pathognomonic for opioid overdose—along with slurred speech and confusion. The person might seem unusually sedated or drowsy compared to their normal baseline. Some people get itchy, some experience nausea. Breathing becomes noticeably slower and shallower; healthy adults typically breathe 12-20 times per minute at rest, but someone in early opioid overdose might drop to 6-10 breaths per minute.

As overdose deepens, lips and fingertips may turn blue (cyanosis), the person stops responding to verbal stimulation, and breathing becomes irregular with periods of apnea (no breathing at all). The person may make a “death rattle” sound—gurgling respirations—as fluid accumulates in the airway. Skin becomes clammy and pale. Heart rate usually decreases.

What’s often missed: the early stage where someone is still partially responsive. Family members see the person breathing, still somewhat awake, and wait. They think “it’s not that bad yet.” But that’s precisely when Narcan works best. Once someone is completely unresponsive and cyanotic, you’re no longer in the optimal intervention window—you’re in crisis management.

Diagnosis During Overdose Emergency

In the emergency department, diagnosis is clinical first, laboratory second. Paramedics and ER physicians look for the constellation of pinpoint pupils, respiratory depression, and altered consciousness. They’ll rapidly assess whether the person can be aroused with verbal or physical stimulation. Pulse oximetry shows oxygen levels (normal is above 95%; overdose patients often show 75-90% or lower). Capnography—measuring exhaled carbon dioxide—demonstrates that ventilation is inadequate.

Lab work comes next: toxicology screens (though standard urine drug screens miss fentanyl and xylazine), arterial or venous blood gas analysis to assess acidosis, and chest X-ray to evaluate for aspiration pneumonia. The speed of diagnosis matters here—every minute of low oxygen delivery to the brain increases risk of permanent neurological damage. Modern EDs use point-of-care blood gas analysis to get results in under a minute rather than waiting for the lab.

From a patient’s perspective (if they survive), the diagnostic period is fragmentary and frightening. They may have vague memories of being shaken, hearing sirens, or waking in the ICU with a breathing tube. This awareness gap—waking up after being revived but with no memory of the overdose itself—is psychologically significant and sometimes triggers another overdose attempt within days.

Treatment Options for Overdose Emergency

Naloxone (Narcan) is the first-line treatment and works by competitively blocking opioids at their receptor sites in the brain and brainstem. It has no abuse potential and relatively few side effects, but here’s what matters: it only works on opioids. If someone overdosed on fentanyl plus xylazine, naloxone reverses only the fentanyl component. The xylazine-induced sedation and respiratory depression continue. Supplemental oxygen is always given simultaneously—the goal is to raise the person’s oxygen saturation above 90% while the naloxone takes effect.

Dosing matters. Intranasal naloxone (Narcan nasal spray) is 4mg per spray and works in 3-5 minutes for most opioid overdoses. Intramuscular naloxone (1mg) takes slightly longer. But fentanyl overdoses sometimes require repeated doses. The ER-based treatment involves IV naloxone, which works faster and can be titrated—the physician gradually increases the dose until respiratory drive returns. Some patients need continuous IV naloxone infusions because the opioid outlasts the single-dose naloxone.

Beyond naloxone, supportive care dominates the treatment strategy. High-flow oxygen via non-rebreather mask or bag-valve-mask ventilation prevents brain damage from hypoxia. Endotracheal intubation and mechanical ventilation are needed if spontaneous breathing remains inadequate after naloxone. Fluid resuscitation corrects acidosis. Observation in the ICU for 4-6 hours is standard because re-sedation can occur as naloxone wears off but opioids remain in the system.

Medications addressing co-occurring conditions matter too. If depression or anxiety contributed to the overdose, starting antidepressants like sertraline or addressing untreated anxiety becomes part of the discharge plan. Linking patients to medication-assisted treatment—buprenorphine or methadone—during their hospital stay dramatically reduces re-overdose risk in the following months.

Practical Daily Management and Overdose Prevention

For people at risk, carrying naloxone isn’t optional—it’s evidence-based harm reduction. The inhaled nasal spray is simpler than auto-injectors and doesn’t require training to be effective. Keep it accessible, not in a locked cabinet. Teach at least two people in your life how to administer it (it’s intuitive—insert the spray into one nostril and press the plunger). Check expiration dates quarterly.

Never use alone. This is the simplest intervention with the strongest evidence. Using with someone present means that person can call 911 immediately rather than waiting hours or having you discovered by chance. Good Samaritan laws in most states protect the person who calls for help from legal consequences, even if they themselves are using drugs.

Know your supply. This sounds obvious but isn’t practiced. If you’re using street drugs, test them. Fentanyl test strips are cheap and available; they won’t catch xylazine, but they catch fentanyl. Start with a smaller amount than usual when returning after abstinence. Have someone who can verify that you’re breathing periodically.

Medication-assisted treatment isn’t aftercare—it’s primary prevention. Buprenorphine (Suboxone) reduces overdose risk by roughly 50% compared to untreated opioid use disorder. Methadone reduces it by 60-70%. These aren’t punitive treatments; they’re neurochemistry-based interventions that stabilize your brain’s opioid system.

Prevention Strategies with Evidence Behind Them

Supervised consumption sites reduce overdose mortality by 35% according to studies from Canada and Europe. These aren’t condoning drug use; they’re acknowledging that overdose death is preventable with the right infrastructure. A nurse is present, naloxone is immediately available, and someone can call for help without legal consequences.

Opioid disposal programs and prescription monitoring reduce overdose risk in a different way—by limiting access

Sources & Medical References

HealthTopics.com articles are based on peer-reviewed medical research and guidance from the NIH, CDC, and WHO. See our editorial policy for full sourcing standards.

Dr. Thomas Reed, MD, PhD
Written by Dr. Thomas Reed, MD, PhD MD, PhD - Board-Certified Pulmonologist
Pulmonology & Critical Care Medicine
Professor of Pulmonary Medicine, University of Colorado

Dr. Thomas Reed is a board-certified pulmonologist and Professor at the University of Colorado with 16 years of expertise in asthma, COPD, sleep apnea, and acute respiratory failure.

View Full Profile →